Supreme Court: Foreign Companies’ Head Office Expenses in India are Capped under Section 44C  ||  SC Directs Trial Courts to Systematically Catalogue Witnesses and Evidence in Criminal Judgments  ||  SC Calls For Sensitising Future Generations on Equality in Marriage to Combat Dowry Practices  ||  SC: Separate Suits Against Confirmed Auction Sales are Barred; Remedy Available under Sec 47  ||  NCLT Mumbai: Oppression Claims Against Majority Shareholders Do not Justify Winding up a Company  ||  J&K&L HC Rules it Illegal and Inequitable to Deny Regularisation to a Daily Wager After 34 Years  ||  J&K&L High Court: Revisional Powers Must Be Used Within Reasonable Time; Merits Don’t Justify Delay  ||  Supreme Court: Compassionate Appointees Cannot Later Claim Entitlement to a Higher Post  ||  NCLAT New Delhi: Insolvency Pleas Cannot Be Admitted When Information Utility Records Show a Dispute  ||  NCLAT: Issuing Cheques For Another Entity’s Liabilities Does not Constitute Operational Debt    

Madras HC Takes Suo Motu Case on Cartel of Doctors, Pharma Companies and Diagnostic Labs - (15 Jan 2020)

MRTP/COMPETITION LAWS

Madras High Court has observed that the cartel of doctors, pharma companies and diagnostic laboratories are fleecing the patients by overpricing the drugs over and above the maximum scale price fixed by the Government. The Court further observed that as a consequence the patients are compelled to pay more unnecessarily.

Tags : MADRAS HIGH COURT   CARTEL OF DOCTORS   PHARMA COMPANIES   DIAGNOSTIC LABORATORIES  

Share :        

Disclaimer | Copyright 2025 - All Rights Reserved